Results 211 to 220 of about 41,384 (251)
Some of the next articles are maybe not open access.
Data Monitoring Committees in adaptive clinical trials
Clinical Investigation, 2013Data Monitoring Committees (DMCs) have been widely utilized in clinical trials for study monitoring. The DMC, independent of any activities related to clinical operation of the study, is a group of individuals with pertinent expertise who review on a regular basis accumulating data from one or more ongoing clinical trials [1].
Min Lin, Shein-Chung Chow
openaire +1 more source
Data monitoring committees for southwest oncology group clinical trials
Statistics in Medicine, 1993AbstractA monitoring committee policy was established by the Southwest Oncology Group in 1985 to address documented problems in study conduct. Committees consisting of the study co‐ordinators, disease committee chair, study statistician, Group chair, Group statistician, an uninvolved Southwest Oncology Group clinician, an NCI representative, and a ...
S, Green, J, Crowley
openaire +2 more sources
On the Independence of Data Monitoring Committee in Adaptive Design Clinical Trials
Journal of Biopharmaceutical Statistics, 2012In clinical trials, an independent data monitoring committee (DMC) is often established to perform both ongoing safety data monitoring and interim efficacy analysis. These evaluations are performed in a blinded fashion in order to avoid possible operational biases that may be introduced to the trial after the review of the data.
Shein-Chung, Chow +2 more
openaire +2 more sources
Clinical Trials, 2006
This is a commissioned report by a writing committee formed by the Society for Clinical Trials. The committee was formed with the objectives of 1) reviewing data monitoring guidelines for confirmatory (phase III) trials published by the National Institutes of Health, US Food and Drug Administration, Veterans Administration, and the International ...
Dennis O, Dixon +6 more
openaire +2 more sources
This is a commissioned report by a writing committee formed by the Society for Clinical Trials. The committee was formed with the objectives of 1) reviewing data monitoring guidelines for confirmatory (phase III) trials published by the National Institutes of Health, US Food and Drug Administration, Veterans Administration, and the International ...
Dennis O, Dixon +6 more
openaire +2 more sources
Data Monitoring Committees in Clinical Trials
2002Data monitoring committees in clinical trials , Data monitoring committees in clinical trials , کتابخانه دیجیتال جندی شاپور ...
Susan S Ellenberg +2 more
openaire +1 more source
Data and Safety Monitoring Committees in Clinical Trials
Journal of Biopharmaceutical Statistics, 2018The book by Dr. Herson is written amazingly well. The book concentrates on pharmaceutical industry-sponsored confirmatory clinical trials and can serve as excellent sources of knowledge for all the...
openaire +1 more source
Decision Analysis for a Data Monitoring Committee of a Clinical Trial
1998A data monitoring committee holds a position of great trust within the structure of a US clinical trial, as it alone receives the accumulating data and decides whether to continue the trial. The committee generally meets at regularly scheduled intervals, e.g. six months.
Joseph B. Kadane +2 more
openaire +1 more source
Coordinating Data Monitoring Committees and Adaptive Clinical Trial Designs
Drug Information Journal, 2008There is a growing interest in employing adaptive clinical trial designs in drug development. Adaptation is usually based on accumulative efficacy data alone. This article examines issues that can arise when an independent data monitoring committee must interface their safety concerns when adaptive changes based on efficacy are taking place.
openaire +1 more source
Data monitoring committees and randomized clinical trials
Kidney International, 2019Howard, Trachtman, Arthur L, Caplan
openaire +2 more sources

